Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled TRial Evaluating Immunosuppressive Treatment in Patients With Chronic Virus-Negative Inflammatory cardiomyopaThY (TRINITY Trial)

NCT05570409 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT05570409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled TRial Evaluating Immunosuppressive Treatment in Patients With Chronic Virus-Negative Inflammatory cardiomyopaThY (TRINITY Trial)
Lead sponsor
LMU Klinikum
Phase
Phase 2/3
Overall status
Terminated
Start date
March 28, 2023
Completion date
April 14, 2025
Enrollment
9 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory cardiomyopathy